31645352Friedman J, Moore EC, Zolkind P, Robbins Y, Clavijo PE, Sun L, Greene S, Morisada MV, Mydlarz WK, Schmitt N, Hodge JW, Schreiber H, Van Waes C, Uppaluri R, Allen CClinical cancer research : an official journal of the American Association for Cancer ResearchAntibodies, Monoclonal; Immunodominant Epitopes; Mouth Neoplasms; Neoadjuvant Therapy; Programmed Cell Death 1 Receptor; T-LymphocytesAnimals; Cell Line, Tumor; Humans; Immunotherapy; Mice; Mice, Inbred C57BL; Tumor Microenvironment; Xenograft Model Antitumor AssaysNeoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells. Clin Cancer Res. 2020 02 01; 26(3):679-689.Clin Cancer Res2019-10-23T00:00:002019Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000818Living Beings1457265180.249624AnimalsD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalD007167Procedures1836270.665954ImmunotherapyD008810Living Beings55730870.60566Mice, Inbred C57BLAuthorship 133715120.1839030.1839031authors10.2514has subject areaD006801Living Beings2262862810.130052HumansD016056Chemicals & Drugs10190.987657Immunodominant EpitopesD009062Disorders531940.835364Mouth NeoplasmsD051379Living Beings980113130.368397MiceD020360Procedures1133150.81805Neoadjuvant TherapyD023041Procedures1684580.868544Xenograft Model Antitumor AssaysD059016Phenomena1404150.763766Tumor MicroenvironmentD061026Chemicals & Drugs911590.882236Programmed Cell Death 1 ReceptorD045744Anatomy46824210.643233Cell Line, TumorD013601Anatomy30511950.618068T-LymphocytesPathologyUniversity of ChicagoHansSchreiberHans Schreiber41.78927490000000-87.601250000000001921Schreiber, HansProfessortrue1ProfessorProfessor